Posted: April 19, 2023
-Contributed by Abi Kasberg, PhD High levels of enthusiasm and excitement were shared at this year’s NASH-TAG meeting in Deer Valley, Utah, regarding the future of the NASH landscape. This was in large part due to the announcement of positive data from two phase 3 clinical trials for new NASH drugs: Madrigal’s Resmetirom and Intercept’s…
Posted: April 19, 2023
-Olivia Stricker, PhD Meetings are back baby! This was the first event that I have been to since the pandemic where it felt 100% back to normal. It was great to get back to it and have others there to get back to it with. In heading to Nashville, DiaPharma/I was in search of answers…
Posted: April 14, 2023
David L. McGlasson, MS, MLS(ASCP) At the recent HTRS 2023 Scientific Symposium, a lively discussion in a Plenary Session was presented titled, “Do We Dare to DOAC?” The HTRS session was moderated by Ayesha N. Zia MD, MSCS and Bethany T. Samuelson, MD, and included three presenters: Introduction to Science: Stephan Moll, MD, University of…
Posted: April 13, 2023
Why isn’t this being funded?! Thoughts from HTRS 2023, and a grant opportunity from DiaPharma Jennifer J. Kiblinger Scientific Director The HTRS 2023 Scientific Symposium gave new insights in hemostasis and thrombosis, from health justice initiatives to the latest in antiphospholipid antibody testing. There were lively and insightful debates, even one on how many steel…
Posted: January 25, 2023
David L. McGlasson, MS, MLS(ASCP) Choosing Wisely is a United States-based health educational campaign led by the American Board of Internal Medicine Foundation (ABIMF) and the Consumers’ Union to reduce the prevalence of unnecessary diagnostic tests and treatments.1 The Choosing Wisely campaign goal is to disseminate information for clinicians and patients that provides diagnostic care…
Posted: January 3, 2023
– Olivia Stricker, PhD and Commercial Business Development Manager at DiaPharma Group I recently attended the AASLD Emerging Topics in Alcohol-associated Liver Disease conference in Philadelphia, PA. Although I had been researching clinical practices in alcohol-associated liver disease (ALD) for the past 6 months, I quickly realized how limited my perspective was from only consuming…
Posted: December 21, 2022
-Contributed by Abi Kasberg, PhD After recently attending the AASLD Emerging Topics in Alcohol-associated Liver Disease conference, it quickly came to my attention the complexities and challenges that are faced while treating alcohol- associated liver diseases (ALD). For one, current treatment options for ALD are incredibly limited. ALD therapies are disputed in effectiveness and can…
Posted: October 7, 2022
Chicago, IL, August 15-18, 2022 David L. McGlasson, MS, MLS(ASCP) The recent THSNA 2022 meeting that was held in Chicago, IL from August 15-18, 2022, was a welcome event, as attendees for the first time in a couple of years could attend the conference in person or virtually. Finally, attendees had the ability to…